Baskent University, Ankara, Turkey.
J Ren Nutr. 2012 Jan;22(1):157-61. doi: 10.1053/j.jrn.2011.10.030.
Hypotheses explaining pathogenesis of secondary hyperparathyroidism (SH) in late and severe CKD as a unique entity called Sagliker syndrome (SS) are still unclear. This international study contains 60 patients from Turkey, India, Malaysia, China, Romania, Egypt, Tunisia, Taiwan, Mexico, Algeria, Poland, Russia, and Iran. We examined patients and first degree relatives for cytogenetic chromosomal abnormalities, calcium sensing receptor (Ca SR) genes in exons 2 and 3 abnormalities and GNAS1 genes mutations in exons 1, 4, 5, 7, 10, 13. Our syndrome could be a new syndrome in between SH, CKD, and hereditary bone dystrophies. We could not find chromosomal abnormalities in cytogenetics and on Ca SR gene exons 2 and 3. Interestingly, we did find promising missense mutations on the GNAS1 gene exons 1, 4, 10, 4. We finally thought that those catastrophic bone diseases were severe SH and its late treatments due to monetary deficiencies and iatrogenic mistreatments not started as early as possible. This was a sine qua non humanity task. Those brand new striking GNAS1 genes missense mutations have to be considered from now on for the genesis of SS.
目前仍不清楚解释晚期和严重慢性肾脏病 (CKD) 中继发甲状旁腺功能亢进症 (SH) 发病机制的假设,即所谓的 Sagliker 综合征 (SS)。本国际研究纳入了来自土耳其、印度、马来西亚、中国、罗马尼亚、埃及、突尼斯、中国台湾、墨西哥、阿尔及利亚、波兰、俄罗斯和伊朗的 60 名患者。我们对患者及其一级亲属进行了细胞遗传学染色体异常、钙敏感受体 (Ca SR) 基因外显子 2 和 3 异常以及 GNAS1 基因外显子 1、4、5、7、10、13 突变检测。我们的综合征可能是 SH、CKD 和遗传性骨营养不良之间的一种新综合征。我们在细胞遗传学和 Ca SR 基因外显子 2 和 3 中均未发现染色体异常。有趣的是,我们确实在外显子 1、4、10、4 上发现了有希望的错义突变。我们最终认为,这些灾难性的骨病是由于经济拮据和治疗时机不当导致的严重 SH 及其晚期治疗所致。这是一项必不可少的人类任务。从现在开始,必须考虑那些全新的 GNAS1 基因突变,以解释 SS 的发病机制。